News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Mujer con trastorno límite de la personalidad
ORYZON strengthens vafidemstat patent portfolio with U.S. Notice of Allowance
Healthcare · Innovative drugs
Covers the use of vafidemstat for treating non-aggressive symptoms of Borderline Personality…
Partners - Oryzon Genomics
Científicas en el laboratorio
Aptadel Therapeutics raises 2 million euros and prepares a new round to bring the project to the clinical phase stage
Healthcare · Drug discovery
Aptadel Therapeutics advances in its treatment for Ewing's sarcoma after closing a bridge round of…
Partners - Parc Científic de Barcelona
Desarrollo de una vacuna en un laboratorio
MTBVAC moves toward its final stage: the vaccine candidate that could mark a turning point in the fight against tuberculosis
Healthcare · Innovative drugs
According to WHO and ECDC data, 161,569 cases were reported in 2024 across 51 of the 53 countries…
AseBio - Zendal
Oryzon anuncia la concesión de una patente
ORYZON announces U.S. patent grant covering iadademstat combinations with venetoclax
Healthcare · Drug discovery · Innovative drugs
Recent data from an ongoing study in first-line AML showed a 100% overall response rate (ORR) with…
Partners - Oryzon Genomics
Miembros del MEP Interest Group sobre Biotech & Life Sciences
AseBio promotes in Brussels the vision of the Spanish biotechnology sector on the Biotech Act I and the future of clinical trials in Europe
Healthcare · Rare diseases · Innovative drugs · Advanced therapies · EU projects
Our Director General, Ion Arocena, participated in the latest meeting of the MEP Interest Group “EU…
GSK inaugura el primer laboratorio de máxima bioseguridad en España
GSK opens Spain’s first maximum biosecurity laboratory
Healthcare · Innovative drugs
Spain Prime Minister, Pedro Sánchez, recently visited the first maximum biosafety level (BSL-4)…
Partners - GSK
Joan Perelló y Arturo Urrios nuevos Managing Partner y Partner
Ysios Capital appoints Joan Perelló as Managing Partner and Arturo Urrios as Partner to drive a new early-stage vertical
Talento · Corporate
Joan Perelló and Arturo Urrios will lead a new vertical focused on company creation and early-stage…
Partners - Ysios Capital Partners
CEO de Arquea Biological Innivations
#NewAseBioMember | "AseBio is the main meeting point for the biotechnology sector in Spain"
Corporate
Meet Arquea Biological Innovations, our new member. We spoke with Fernando Garcia…
AseBio - Arquea Biological Innovations
CEO de Macami Biotech
#NewAseBioMember | “AseBio represents credibility, sector cohesion, and a unified voice”
Corporate
Meet Macami Biotech, our new member. We spoke with Miguel Rodríguez-Villa Förster…
AseBio - MACAMI BIOTECH